EC
TMDX icon

Elequin Capital’s Transmedics TMDX Stock Holding History

Elequin Capital’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.68K Sell
37
-70
-65% -$9.13K ﹤0.01% 417
2025
Q4 		$13K Buy
+107
New +$13.4K ﹤0.01% 217
2025
Q1 		– Sell
-88
Closed -$5.49K – 628
2024
Q4 		$5.49K Buy
+88
New +$8.19K ﹤0.01% 393
2024
Q2 		– Sell
-119
Closed -$8.8K – 348
2024
Q1 		$8.8K Buy
+119
New +$9.81K ﹤0.01% 115
2023
Q3 		– Sell
-16
Closed -$1.34K – 601
2023
Q2 		$1.34K Buy
+16
New +$1.23K ﹤0.01% 467

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Elequin Capital's TMDX Position: Q1 2026 in Review

Elequin Capital reduced its Transmedics (TMDX) stake by 65% in Q1 2026, selling an estimated $9.13K and leaving 37 shares worth $3.68K. The position accounts for ﹤0.01% of the portfolio, ranked #417.

Elequin Capital first reported a position in TMDX in Q2 2023 and has held it in 5 quarters since. The position peaked at $13K in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Elequin Capital held 37 shares of Transmedics worth $3.68K as of Q1 2026.
  • Elequin Capital sold 70 Transmedics shares in Q1 2026, an estimated $9.13K.
  • Transmedics made up ﹤0.01% of Elequin Capital's portfolio in Q1 2026, its #417 holding.
  • Elequin Capital first reported a position in Transmedics in Q2 2023 and has held it in 5 quarters since.
  • Elequin Capital's Transmedics position peaked at $13K in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Elequin Capital's 13F filing for Q1 2026, filed 11 May 2026.